Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 56.975 USD 1.42%
Market Cap: 10.7B USD

Relative Value

The Relative Value of one EXAS stock under the Base Case scenario is hidden USD. Compared to the current market price of 56.975 USD, Exact Sciences Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EXAS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
71
Median 3Y
4.4
Median 5Y
5.3
Industry
7.1
Forward
3.4
vs History
vs Industry
Median 3Y
-23.6
Median 5Y
-25.8
Industry
23
Forward
-100.8
vs History
53
vs Industry
4
Median 3Y
49.3
Median 5Y
49.3
Industry
19.4
vs History
11
vs Industry
5
Median 3Y
46.4
Median 5Y
15.9
Industry
23.1
vs History
36
vs Industry
27
Median 3Y
3.7
Median 5Y
4
Industry
2.6
vs History
82
vs Industry
58
Median 3Y
5
Median 5Y
6
Industry
7.5
Forward
3.9
vs History
80
vs Industry
56
Median 3Y
6.9
Median 5Y
8.4
Industry
9.4
vs History
20
vs Industry
0
Median 3Y
-23.6
Median 5Y
-36.1
Industry
4.4
Forward
27.6
vs History
vs Industry
Median 3Y
-50.8
Median 5Y
-49.9
Industry
4.5
Forward
-141.9
vs History
53
vs Industry
4
Median 3Y
54.9
Median 5Y
54.9
Industry
5.2
vs History
15
vs Industry
0
Median 3Y
-23.8
Median 5Y
-47.9
Industry
3.7
vs History
47
vs Industry
46
Median 3Y
2.3
Median 5Y
2.5
Industry
4.8

Multiples Across Competitors

EXAS Competitors Multiples
Exact Sciences Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Exact Sciences Corp
NASDAQ:EXAS
10.7B USD 3.8 -10.5 254.9 -73.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 698 702.5 -164 917.8 -200 262.8 -197 977.5
US
Abbvie Inc
NYSE:ABBV
334.7B USD 5.8 80.6 15.3 22.7
US
Amgen Inc
NASDAQ:AMGN
157.8B USD 4.6 26.6 14.3 23.6
US
Gilead Sciences Inc
NASDAQ:GILD
137.1B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116B USD 10.5 -117.3 24.9 26.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 030.3 -518.1 -564.1 -549.1
AU
CSL Ltd
ASX:CSL
116.6B AUD 5 27.7 17.1 21.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
56.6B USD 4 12.6 11.2 12.6
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60 -64.6 -58.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
39.4B USD 16.8 -146.1 -653.9 -327.7
P/E Multiple
Earnings Growth PEG
US
Exact Sciences Corp
NASDAQ:EXAS
Average P/E: 34.1
Negative Multiple: -10.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 917.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.6
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.6
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -117.3 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -518.1 N/A N/A
AU
CSL Ltd
ASX:CSL
27.7
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.6
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -146.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Exact Sciences Corp
NASDAQ:EXAS
Average EV/EBITDA: 49.7
254.9
185%
1.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -200 262.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.3
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.3
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.1 N/A N/A
AU
CSL Ltd
ASX:CSL
17.1
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.2
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -653.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Exact Sciences Corp
NASDAQ:EXAS
Average EV/EBIT: 20
Negative Multiple: -73.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 977.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.7
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.6
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -549.1 N/A N/A
AU
CSL Ltd
ASX:CSL
21.4
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.6
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -327.7 N/A N/A